T1	Pharmacological_substance 73 84	simvastatin
N1000 	Reference T1 MeSH:D019821	simvastatin
T2	Pharmacological_substance 89 100	pravastatin
N1001 	Reference T2 MeSH:D017035	pravastatin
T10	Pharmacological_substance 352 363	simvastatin
N1002 	Reference T10 MeSH:D019821	simvastatin
T11	Pharmacological_substance 399 410	pravastatin
N1003 	Reference T11 MeSH:D017035	pravastatin
T14	Pharmacological_substance 677 688	simvastatin
N1004 	Reference T14 MeSH:D019821	simvastatin
T16	Pharmacological_substance 699 710	pravastatin
N1005 	Reference T16 MeSH:D017035	pravastatin
T17	Pharmacological_substance 928 939	simvastatin
N1006 	Reference T17 MeSH:D019821	simvastatin
T19	Pharmacological_substance 1007 1031	simvastatin hydroxy acid
N1007 	Reference T19 MeSH:C063287	simvastatin hydroxy acid
T20	Pharmacological_substance 1126 1150	simvastatin hydroxy acid
N1008 	Reference T20 MeSH:C063287	simvastatin hydroxy acid
T22	Pharmacological_substance 1430 1441	pravastatin
N1009 	Reference T22 MeSH:D017035	pravastatin
T23	Pharmacological_substance 1539 1550	simvastatin
N1010 	Reference T23 MeSH:D019821	simvastatin
T24	Pharmacological_substance 1554 1565	pravastatin
N1011 	Reference T24 MeSH:D017035	pravastatin
T25	Pharmacological_substance 1699 1710	simvastatin
N1012 	Reference T25 MeSH:D019821	simvastatin
T27	Pharmacological_substance 1755 1766	simvastatin
N1013 	Reference T27 MeSH:D019821	simvastatin
T32	Pharmacological_substance 1994 2005	simvastatin
N1014 	Reference T32 MeSH:D019821	simvastatin
T3	Pharmacological_substance 1722 1733	pravastatin
N1015 	Reference T3 MeSH:D017035	pravastatin
T12	Pharmacological_substance 368 393	inactive lactone pro-drug
T15	Subject 443 512	Sixteen healthy male subjects (n = 8 in group 1 and n = 8 in group 2)
T36	Pharmacological_substance 563 570	placebo
N1016 	Reference T36 MeSH:D010919	placebo
T38	Subject 724 743	subjects in group 1
T40	Subject 724 732;748 756	subjects group 2,
